

Biocon Biologics Profile
Key Indicators
- Authorised Capital ₹ 3,500.00 Cr
- Paid Up Capital ₹ 1,758.31 Cr
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16,501.50 Cr
- Satisfied Charges ₹ 10,141.76 Cr
- Revenue Growth 21.86%
- Profit Growth -58.99%
- Ebitda -7.01%
- Net Worth 3.48%
- Total Assets 7.46%
About Biocon Biologics
Biocon Biologics Limited (BBL) is a Public Limited Indian Non-Government Company incorporated in India on 08 June 2016 (Eight years and nine months 19 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Biocon Biologics India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3,500.00 Cr and a paid-up capital of Rs 1,758.31 Cr.
The company currently has active open charges totaling ₹16,501.50 Cr. The company has closed loans amounting to ₹10,141.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biocon Biologics Limited India are Shreehas Tambe as Ceo, Akhilesh Nand as Company Secretary, and Mr Upadhye as Cfo. Bobby Parikh, Rajiv Malik, Daniel Bradbury, and Seven other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24119KA2016PLC093936
- Company No.
093936
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jun 2016
- Date of AGM
26 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biocon Biologics?
Executive Team (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shreehas Tambe ![]() | Managing Director | 05-Dec-2022 | Current |
Akhilesh Nand ![]() | Company Secretary | 21-Aug-2024 | Current |
Mr Upadhye ![]() | CFO | Current |
Board Members (9)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nivruti Rai ![]() | Director | 01-Aug-2019 | Current |
Kiran Shaw ![]() | Whole-Time Director | 08-Jun-2016 | Current |
Daniel Bradbury ![]() | Director | 01-Aug-2019 | Current |
Bobby Parikh ![]() | Director | 01-Aug-2019 | Current |
Rajiv Malik ![]() | Nominee Director | 29-Nov-2022 | Current |
Peter Piot ![]() | Director | 21-Jan-2021 | Current |
Financial Performance of Biocon Biologics.
Biocon Biologics Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.86% increase. The company also saw a substantial fall in profitability, with a 58.99% decrease in profit. The company's net worth moved up by a moderate rise of 3.48%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biocon Biologics?
In 2023, Biocon Biologics had a promoter holding of 92.04% and a public holding of 7.96%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Mylan Laboratories Limited
Rajiv Malik is a mutual person
- Science Gallery Bengaluru
Kiran Shaw is a mutual person
- Mazumdar Shaw Medical Foundation
Kiran Shaw is a mutual person
- Immuneel Therapeutics Private Limited
Kiran Shaw is a mutual person
- Trent Limited
Kiran Shaw is a mutual person
- Csep Research Foundation
Kiran Shaw is a mutual person
Charges (Loans)
₹16,501.50 Cr
₹10,141.76 Cr
Charges Breakdown by Lending Institutions
- Others : 16151.50 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 350.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
09 Dec 2024 | Others | ₹847.30 Cr | Open |
22 Nov 2024 | Others | ₹6,808.76 Cr | Open |
03 Mar 2023 | Others | ₹7,947.94 Cr | Open |
30 Oct 2020 | The Hongkong And Shanghai Banking Corporation Limited | ₹350.00 Cr | Open |
14 Dec 2018 | Others | ₹547.50 Cr | Open |
How Many Employees Work at Biocon Biologics?
Biocon Biologics has a workforce of 5280 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Biocon Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Biologics's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Biocon Biologics
Recent activity within the organization
- Charges
A charge registered on 06 Mar 2023 via Charge ID 100701655 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 17 Dec 2024.
- Charges
A charge with Others amounted to Rs. 847.30 Cr with Charge ID 101019160 was registered on 09 Dec 2024.
- Charges
A charge with Others amounted to Rs. 6,808.76 Cr with Charge ID 101017580 was registered on 22 Nov 2024.
- Director Appointment
Akhilesh Kumar Nand was appointed as a Company Secretary was appointed as a Company Secretary on 21 Aug 2024 & has been associated with this company since 7 months 6 days .
- Annual General Meeting
Biocon Biologics Limited last Annual general meeting of members was held on 26 Jul 2024 as per latest MCA records.
- Charges
A charge with Others of Rs. 7,947.94 Cr registered on 03 Mar 2023 with Charge ID 100692461 was modified on 25 Jul 2024.
Recent News, Updates & Announcement
Frequently asked questions
What is the Incorporation or founding date of Biocon Biologics Limited?
Biocon Biologics Limited was incorporated on 08 Jun 2016.
What is authorized share capital and paid-up capital of Biocon Biologics Limited?
The authorized share capital of Biocon Biologics Limited is ₹ 3,500.00 Cr and paid-up capital is ₹ 1,758.31 Cr.
Who are the current board members & directors of Biocon Biologics Limited?
Currently 13 directors are associated with Biocon Biologics Limited.
- Bobby Kanubhai Parikh
- Rajiv Malik
- Daniel Mark Bradbury
- Peter Baron Piot
- Thomas Jason Roberts
- Shreehas Pradeep Tambe
- Shreehas Pradeep Tambe
- Nicholas Robert Haggar
- Arun Suresh Chandavarkar
- Nivruti Rai
- Kiran Mazumdar Shaw
- Akhilesh Kumar Nand
- Mr Kedar Upadhye
What is the registered address of Biocon Biologics Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Biocon Biologics Limited is Biocon House Ground Floor Tower-3 Semicon Park Electronic City Phase - Ii, Hosur Road India, Bengaluru, Karnataka, 560100.
What is the corporate identification number (CIN) and company number of Biocon Biologics Limited?
The corporate identification number (CIN) of Biocon Biologics Limited is U24119KA2016PLC093936 and the company number is 093936 as per Ministry of Corporate Affairs (MCA).
What is the official website of Biocon Biologics Limited?
The Official website of Biocon Biologics Limited is https://www.biocon.com
What has been the recent revenue trend for Biocon Biologics Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Biocon Biologics Limited has risen by 21.86%.
How many employees does Biocon Biologics Limited currently have?
As Per 2022 financial reports, 5280 employees are currently employed by Biocon Biologics Limited.
What change has been observed in the net worth of Biocon Biologics Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Biocon Biologics Limited has experienced an upsurge of 3.48%.
What are the total open charges for Biocon Biologics Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Biocon Biologics Limited amount to ₹ 16,501.50 Cr.
When was the last Balance Sheet of Biocon Biologics Limited filed with the ROC?
The most recent Balance Sheet for Biocon Biologics Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
JW
John WallsDirectorSS
Satishkumar SeetharamaiahDirectorCH
Christiane HamacherManaging Director